Materials and methods
Eighteen recreationally active males volunteered for the study. Participants were considered sufficiently active for inclusion in the study if they met Canada’s physical activity guidelines.14 Each participant was a non-smoker and had no history of respiratory or cardiovascular disease. The Clinical Research Ethics Board of the University of British Columbia approved this study. Prior to all visits, participants were asked to refrain from exhaustive exercise and alcohol for 24 hours, caffeine for 6 hours and food or non-water beverages for 2 hours. Each participant performed all trials at the same time of day. Participants were also asked to maintain the same pretest routine including the same mode of travel to the laboratory and pretest meal, and were asked to restrict vitamin supplementation for the duration of the study. The sample size was calculated based on a minimal detectable difference in soluble platelet-Selectin (sP-Selectin) of 2.8 ng/mL using an effect size of 0.87 (f), a power of 0.8 and an alpha of 0.0515 and a minimal detectable difference in neutrophils of 49.2% increase using an effect size of 0.65 (f), a power of 0.8 and an alpha of 0.05.16
Experimental design
Data collection for this study occurred as part of a larger study, and overall methods are explained in detail elsewhere.17–19 Briefly, each participant attended the laboratory on seven occasions. The initial visit served as a familiarisation with all study procedures and performance of a maximal exercise test on a cycle ergometer. Details of the maximal exercise test, as well as the exercise testing equipment can be found in detail elsewhere.17–19
On testing days 2–7, participants performed 30 min trials of low-intensity cycling, high-intensity cycling or rest. Each intensity was performed once in filtered air (FA) and once in DE with a target concentration of 300 µg/m3 of PM2.5, for a total of six trials, each of which was separated by a 7-day period. Exercise intensity and the exposure (FA and DE) were randomised. To avoid experimental bias, both the participant and the research assistant collecting the data were blinded to the exposure of FA or DE. Work rates on cycling days were based on the peak power achieved during the maximal exercise test. Low-intensity cycling was set at 30% of the power at peak oxygen consumption (VO2peak) (mean (SD): 96.1 (17.7) W) and high-intensity cycling was set at 60% of power at VO2peak (192.2 (35.3) W). Control exposures involved sitting for the same period of time (30 min), but without performing exercise. Information regarding the exercise set-up can be found in detail elsewhere.17 19 Prior to, immediately post, 1 hour and 2 hours post exposure, blood was drawn to measure parameters of a complete blood count and adhesion molecules that are detailed below.
Outcome measures
Blood samples were taken from the right antecubital fossa with a 21-gauge needle. White blood cell (WBC), neutrophil, monocyte, lymphocyte, eosinophil, platelet, red blood cell (RBC), haemoglobin concentrations and haematocrit (Hct) were measured in a commercial laboratory. Blood samples were also taken to determine concentrations of sICAM-1, sVCAM-1, sP-Selectin and soluble endothelial-Selectin (sE-Selectin). These samples were immediately centrifuged at 1500g for 20 min to separate plasma from formed elements. Plasma was extracted, frozen and stored at −80°C until assayed. Plasma concentrations of sICAM-1, sVCAM-1, sP-Selectin and sE-Selectin were determined in duplicate using commercially available Luminex assay kits (Human Adhesion Molecule Luminex Performance Assay; R&D Systems, Minnesota, USA), according to the procedures outlined by the manufacturer and using a Luminex 200 System (Luminex, Ontario, Canada). The intra-assay coefficient of variation for sICAM-1 was 4.4%, sVCAM-1 was 3.8%, sP-Selectin was 4.4% and sE-Selectin was 3.6%. Of the 432 planned blood samples, two were unable to be collected for technical reasons. To prevent complete exclusion of those subjects with missing measurements and based on the recommendations of a statistician, the missing values were imputed using regression.20
As plasma volume may change during exercise, levels of sICAM-1, sVCAM-1, sP-Selectin and sE-Selectin were adjusted for changes in plasma volume from baseline, which is explained in detail elsewhere.17 18
Exposure set-up
All exposures were performed using an environmental exposure booth and that is explained in detail elsewhere,21 but was modified only in that the generator load was kept constant at 2.5 kW and not cycled. For DE exposures, participants were exposed to calibrated, aged and diluted DE with a target concentration of 300 µg/m3 of PM2.5. For FA exposures, participants were exposed to room air after it was concentrated and then passed through a high-efficiency particulate air filter. All equipments used to determine pollutant concentrations are also explained in detail elsewhere.17–19 Briefly, in-booth PM mass concentration measurements were made using a Tapered Element Oscillating Microbalance (Model 1400a; Rupprecht & Pattashnick, Albany, New York, USA). A TSI Scanning Mobility Particle Scanner (Model 3936; TSI, Shoreview, Minnesota, USA) classified the particle size distribution between 2.5 nm and 1000 nm. DE was chosen to represent a mixture similar to that in an urban street canyon. For example, in a street canyon in close proximity to a major highway peak particle number concentration (PNC) was similar to experimental exposures conducted in our laboratory, where PNC exceeds 300 000 particles/cm3.21 22 Furthermore, 30 min peak carbon monoxide concentrations in downtown street canyons exceed carbon monoxide concentrations within our laboratory (17.5–35 parts per million (ppm) vs 11.2 ppm in the current study).21 23 This dose of DE is occupationally relevant and has been experienced by miners, construction workers, mechanics and dockside workers.24–26 The concentration of PM2.5 is approximately 1 order of magnitude greater than 24 hours ambient standard in Canada.
Statistical analysis
Statistical analyses were completed using SPSS V.20 software (SPSS, Chicago, Illinois, USA), and analyses were chosen through consultation with a PhD statistician. For each parameter, data were analysed using a 2 (exposure: FA vs DE) × 3 (intensity: rest, low intensity, high intensity) × 4 (time: pre, post, 1 hour post, 2 hours post) repeated measures analysis of variance (ANOVA). Significance was set at p<0.05. For all repeated measures ANOVA, the Huynh-Feldt adjustment was used to correct for violations of sphericity. Main or interaction effects were further analysed using pairwise comparisons, and significance was adjusted to account for multiple comparisons using the Sidak adjustment, which is explained in detail elsewhere.17–19 Briefly, the p-values represented in this manuscript have been inflated to incorporate the Sidak adjustment, meaning that remains at 0.05. Baseline data were analysed using a 2 (exposure: FA vs DE) × 3 (intensity: rest, low intensity, high intensity) repeated measures ANOVA. All means are reported with SD in parentheses.
Patient and public involvement
We did not involve patients or the public in the design of the research project or research questions. The public were recruited as participants, which has been previously explained in detail.